An increased prevalence between patent formen ovale (PFOs) and migraine exists but there is conflicting data regarding causal relationship between these two conditions. It is controversial whether cardiac screening and intervention like PFO closure provides any benefit in this population and so this area still remains under intense investigation. The management of migraine lies at the intersection between the practice of primary care physicians, neurologists, and cardiologists. There is no consensus as to what is the best practice for the evaluation of these patients with difficult to control migraine given the millions of dollars spent on physician visits and pharmacotherapy. This review seeks to summarize the current literature on this association and studies that have investigated PFO closure in this population. (Echocardiography 2011;28:913-917)

References

1 Weber F, Goriup A: Prevalence of right to-left shunts in active fighter pilots. Aviation Space Environ Med 2007; 78: 135–136.
PubMed Web of Science® Google Scholar
2 Zeller JA, Frahm K, Baron R, et al: Platelet-Leukocyte Interaction and Platelet Activation in Migraine: A link to ischemic stroke? J Neurol Neurosurg Psychiatry 2004; 75: 984–987.
10.1136/jnnp.2003.019638
CAS PubMed Web of Science® Google Scholar
3 Naqvi T, Rafie R, Daneshvar S: Potential Faces of Patent Foramen Ovale. Echocardiogr 2010; 27: 897–907.
10.1111/j.1540-8175.2010.01165.x
PubMed Web of Science® Google Scholar
4 Schwedt TJ, Demaerschalk BM, Dodick DW: Patent foramen ovale and migraine: A quantitative systematic review. Cephalagia 2008; 28: 531–540.
10.1111/j.1468-2982.2008.01554.x
CAS PubMed Web of Science® Google Scholar
5 Rundek T, Elkind MS, Di Tullio MR, et al: Patent foramen ovale and migraine: A cross-sectional study from the Northern Manhattan Study (NOMAS). Circulation 2008; 118: 1419–1424.
10.1161/CIRCULATIONAHA.108.771303
PubMed Web of Science® Google Scholar
6 Garg P, Servoss SJ, Wu JC, et al: Lack of association between migraine headache and patent foramen ovale: Results of a case-control study. Circulation 2010; 112: 1406–1412.
10.1161/CIRCULATIONAHA.109.895110
PubMed Web of Science® Google Scholar
7 Zito C, Dattillo G, Oreto G, et al: Patent Foramen Ovale: Comparison Among Diagnostic Strategies in Cryptogenic Stroke and Migraine. Echocardiogr 2009; 26: 495–503.
10.1111/j.1540-8175.2008.00852.x
CAS PubMed Web of Science® Google Scholar
8 Woods TD, Harmann L, Purath T et al: Small and Moderate Size Right to Left Shunts by Saline Contrast Echo are Normal/Unrelated to Migraine. Chest 2010; 138: 264–269.
10.1378/chest.09-2797
PubMed Web of Science® Google Scholar
9 Del Sette M, Angeli S, Leandri M, et al: Migraine with Aura and Right to Left Shunt on Transcranial Doppler: A Case Control Study. Cerebrovasc Dis 1998; 8: 327–330.
10.1159/000015875
CAS PubMed Web of Science® Google Scholar
10 Jesurum JT, Fuller CJ, Velez CA, et al: Migraineurs with Patent Foramen Ovale have a larger right-to-left shunt despite similar atrial septal characteristics. J Headache Pain 2007; 8: 209–216.
10.1007/s10194-007-0396-5
PubMed Web of Science® Google Scholar
11 Kaaro J, Partonen , Naik P, et al: Is Migraine a Lateralization defect? Neuroreport 2008; 19: 1351–1353.
10.1097/WNR.0b013e32830c4698
PubMed Web of Science® Google Scholar
12 Steenblik MH, Mineau GP, Pimentel R, et al: Population-based assessment of familial inheritance and neurologic co-morbidities among patients with an isolated atrial septal defect. Congenital Heart Dis 2009; 4: 459–463.
10.1111/j.1747-0803.2009.00340.x
PubMed Web of Science® Google Scholar
13 Prandota J: Migraine associated with patent foramen ovale may be caused by reactivation of cerebral toxoplasmosis triggered by arterial blood oxygen desaturation. Int J Neurosci 2010; 120: 81–87.
10.3109/00207450903458647
CAS PubMed Web of Science® Google Scholar
14 Botto N, Spadoni I, Giusti S, et al: Prothrombotic mutations as risk factors for cryptogenic ischemic cerebrovascular events in young patients with patent foramen ovale. Stroke 2007; 38: 2070–2073.
10.1161/STROKEAHA.106.480863
CAS PubMed Web of Science® Google Scholar
15 Di Fabio R, Giugni E, Angeloni I, et al: Contrast echocardiography and migraine in divers with patent foramen ovale. Can J Neurol Sci 2009; 36: 740–744.
10.1017/S0317167100008362
PubMed Web of Science® Google Scholar
16 Adami A, Rossato G, Cerini R, et al: Right to Left Shunt does not increase white matter lesion load in migraine with aura patients. Neurology 2008; 71: 101–107.
10.1212/01.wnl.0000316798.25510.f2
CAS PubMed Web of Science® Google Scholar
17 Wahl A, Praz F, Tai T, et al: Improvement of migraine headaches after percutaneous closure of patent foramen ovale for secondary prevention of paradoxical embolism. Heart 2010; 96: 967–973.
10.1136/hrt.2009.181156
PubMed Web of Science® Google Scholar
18 Dowson A, Mullen MJ, Peatfield R, et al: Migraine Intervention With STARFlex Technology (MIST) trial: A prospective, multicenter, double-blind, sham-controlled trial to evaluate the effectiveness of patent foramen ovale closure with STARFlex septal repair implant to resolve refractory migraine headache. Circulation 2008; 117: 1397–1404.
10.1161/CIRCULATIONAHA.107.727271
PubMed Web of Science® Google Scholar
19 Moaref AR, Petramfar P, Aghasadesi K, et al: Patent foramen ovale in patients with tension headache: Is it as Common as in Migraineurs? An age- and sex matched comparative study. J Headache Pain 2009; 10: 431–434.
10.1007/s10194-009-0154-y
PubMed Web of Science® Google Scholar
20 Vigna C, Marchese N, Inchingolo V, et al: Improvement of migraine after patent foramen ovale percutaneous closure in patients with subclinical brain lesions: A case control study. JACC: Cardiovasc Interventions 2009; 2: 107–113.
10.1016/j.jcin.2008.10.011
PubMed Web of Science® Google Scholar
21 Papa M, Gaspardone A, Fragasso G, et al: Usefulness of transcatheter patent foramen ovale closure in migraineurs with moderate to large right to left shunt and instrumental evidence of cerebrovascular damage. Am J Cardiol. 2009; 104: 434–439.
10.1016/j.amjcard.2009.03.061
PubMed Web of Science® Google Scholar
22 Jesurum JT, Fuller CJ, Kim CJ, et al: Frequency of migraine headache relief following patent foramen ovale ‘closure’ despite residual right-left shunt. Am J Cardiol 2008; 102: 916–920.
10.1016/j.amjcard.2008.05.035
PubMed Web of Science® Google Scholar
23 Rigatelli G, Cardaioli P, Dell’Avvocata F: Early post-procedural migraine attack predicts migraine resolution after patent ovale foramen ovale transcatheter closure. Minerva Cardioangiol 2008; 56: 461–465.
CAS PubMed Google Scholar
24 Reisman M, Christofferson RD, Jerusum J: Migraine headache relief after transcatheter closure of patent foramen ovale. J Am Coll Cardiol 2005; 45: 493–495.
10.1016/j.jacc.2004.10.055
PubMed Web of Science® Google Scholar

Citing Literature

Volume28, Issue8

September 2011

Pages 913-917

Role of Patent Foramen Ovale in Migraine Etiology and Treatment: A Review

Abstract

References

Citing Literature

References

Information

About Wiley Online Library

Help & Support

Opportunities

Connect with Wiley

Role of Patent Foramen Ovale in Migraine Etiology and Treatment: A Review

Abstract

References

Citing Literature

References

Related

Information